Tirzepatide may change how the body uses energy, trial suggests

Article excerpt

A clinical trial presented at the Endocrine Society's annual meeting in Chicago found that tirzepatide, a diabetes and weight-loss drug, does more than shrink waistlines. The medication activates brown adipose tissue, the metabolically active fat that burns calories to generate heat. This discovery suggests the drug works through a previously underappreciated mechanism: altering how the body itself uses energy at the cellular level. Researchers described the finding as a major milestone in obesity treatment, potentially opening new angles for understanding why tirzepatide outperforms older weight-loss medications.